Precocious puberty
endocrine · Paediatric
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Onset of secondary sexual characteristics before age 8 in girls or 9 in boys. Central (gonadotropin-dependent) causes predominate in girls and are often idiopathic, but in boys and in rapid progression a pathological cause is more likely.
Red flags
- Rapidly progressive puberty with marked bone age advance (threat to adult height)
- Precocious puberty in a boy (higher chance of pathology, image the brain)
- Neurological signs or headache (CNS lesion)
- Signs of virilisation or an abdominal mass (tumour/CAH)
Assessment
Differential diagnosis
- Central (gonadotropin-dependent) precocious puberty (idiopathic or CNS lesion)
- Peripheral (gonadotropin-independent) precocious puberty (CAH, tumours, McCune-Albright)
- Premature thelarche (isolated breast development)
- Premature adrenarche (isolated pubic hair)
- Exogenous sex steroid exposure
- Hypothyroidism (severe, with precocity)
- Normal variant early puberty
Investigations
- Pubertal staging, growth velocity and bone age (advanced in true precocity)
- Basal and GnRH-stimulated LH/FSH to classify central vs peripheral
- Oestradiol/testosterone levels
- Pelvic ultrasound (girls) for uterine/ovarian maturation
- MRI brain for central precocity (especially boys or neurological features)
- 17-OHP, adrenal androgens, hCG, thyroid function as directed
Management
- Confirm true pubertal development and distinguish from benign variants
- Assess growth acceleration and advanced bone age
- Measure gonadotropins (basal and stimulated) to classify central vs peripheral
- Measure sex steroids and seek a peripheral source if gonadotropin-independent
- Image the brain for central precocity, especially in boys
- Investigate peripheral causes (adrenal, gonadal, CAH, McCune-Albright)
- Refer to paediatric endocrinology
- Treat central precocious puberty with GnRH analogues to halt progression and preserve height
- Treat the underlying cause of peripheral precocity
Drugs & doses
GnRH analogue (e.g. leuprorelin/triptorelin depot) to suppress central precocious puberty (specialist)
Treat underlying cause for peripheral precocity (e.g. hydrocortisone for CAH)
Aromatase inhibitors/anti-androgens in selected peripheral causes (specialist)
No treatment for benign premature thelarche/adrenarche; monitor
Disposition
Paediatric endocrinology referral; expedite for boys, rapid progression, or neurological features.
Complications & pitfalls
- Reduced final adult height from premature epiphyseal fusion
- Psychosocial difficulties from early maturation
- Underlying serious pathology (CNS or adrenal/gonadal tumour)
- Progression of untreated peripheral cause
Exam pearls
- Precocious puberty in boys is more likely pathological and warrants brain imaging
- Isolated breast development (premature thelarche) in a young girl is usually benign and non-progressive
- Advanced bone age with rapid progression threatens final height and favours treatment
- A GnRH stimulation test distinguishes central from peripheral causes
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.